The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression

Journal of Affective Disorders

Volumn 35, Issue 1-2, 1995, Pages 51-57

  Nelson, Elliot C ^a   Cloninger, C Robert ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Major depressive disorder; Nefazodone; Obsessive compulsive disorder; Tridimensional personality questionnaire

Indexed keywords

NEFAZODONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; PERSONALITY; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY DEVELOPMENT; PERSONALITY INVENTORY; PROGNOSIS; PSYCHOMETRICS; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; TRIAZOLES;

EID: 0028788382     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(95)00038-O     Document Type: Article

References (33)

1. Compulsive personality as predictor of response to serotoninergic antidepressants
2. The relationship of personality to mood and anxiety states: a dimensional approach
3. A systematic method for clinical description and classification of personality variants
4. The tridimensional personality questionnaire: U.S. normative data
5. Placebo-controlled dose-ranging trial designs in phase II development of nefazodone
6. The relationship of affective illness and personality disorders in psychiatric outpatients
7. Does personality predict long-term outcome in depression?
8. A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression
9. A double-blind comparison of nefazodone, imipramine and placebo in major depression
10. Relationship between the tridimensional personality questionnaire and DSM-III-R personality traits
11. A rating scale for depression
12. Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck
13. Personality and response to tricyclic antidepressants in depressed patients
14. The tridimensional personality questionnaire in major depression
15. Predictors of treatment response and treatment selection
16. Predictors of drug response in depression
17. Temperament predicts clomipramine and desipramine response in major depression
18. The predictors of persistence of depression in primary care
19. The relationship of sociotropy and autonomy to symptoms, cognition and personality in depressed patients
20. Cloninger's tridimensional theory of personality: construct validity in a sample of college students
21. Sociotropy and autonomy: relationship to antidepressant drug treatment response and endogenous-nonendogenous dichotomy
22. The implications of DSM-III personality disorders for patients with major depression
23. Nefazodone and Imipramine in major depression: a placebocontrolled trial
24. Can we predict the persistence of depression?
25. The relationship between premorbid neuroticism, cognitive dysfunction and persistence of depression: a 1-year follow-up
26. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program
27. Stallings, M., Hewitt, J., Cloninger, C.R., Heath, A. and Eaves, L. (in press) Genetic and environmental structure of the tridimensional personality questionnaire: three or four primary temperament dimensions. J. Pers. Soc. Psychol.
28. Mood states and personality traits
29. Differential diagnosis of personality disorders by the seven factor model of temperament and character
30. The tridimensional personality questionnaire structural validity and comparison with the multidimensional personality questionnaire